Abbott Labs

ABT Large Cap

Healthcare · Medical Devices

Updated: Apr 5, 2026, 00:03 UTC

$102.87

+0.48% today

52W: $100.88 – $139.06

52W Low: $100.88 Position: 5.2% 52W High: $139.06

🔗 Compare Brokers Best Broker for Beginners →

Key Metrics

P/E Ratio

27.65x

Price-to-Earnings

Forward P/E

16.85x

Forward Price/Earnings

P/S Ratio

4.03x

Price-to-Sales

EV/EBITDA

15.34x

Enterprise Value/EBITDA

Div. Yield

245%

Annual dividend yield

Market Cap

$178.8B

Market Capitalization

Revenue Growth

4.4%

YoY Revenue Growth

Profit Margin

14.72%

Net profit margin

ROE

12.96%

Return on Equity

Beta

0.78

Market sensitivity

Short Interest

1.28%

% of float sold short

Avg. Volume

11,383,616

Average daily volume

Valuation Analysis

Signal

Fair

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

25 analysts

Avg. Price Target

$132.28

+28.59% upside

Target Range

$113.00 – $158.00

🚫 Not currently held by any of our 15 tracked Smart Money managers. View Smart Money Tracker →

About the Company

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides

Sector: Healthcare Industry: Medical Devices Country: United States Employees: 115,000 Exchange: NYQ